Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
Gastrointestinal
Grading
Neuroendocrine carcinoma
Neuroendocrine neoplasms
Neuroendocrine tumor
Staging
WHO classification
Journal
Surgical pathology clinics
ISSN: 1875-9157
Titre abrégé: Surg Pathol Clin
Pays: United States
ID NLM: 101491209
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
15
7
2021
Statut:
ppublish
Résumé
The latest WHO classification cleanly divides gastrointestinal neuroendocrine neoplasms into neuroendocrine tumor (NET; well-differentiated, any grade) and neuroendocrine carcinoma (NEC; poorly differentiated, high-grade by definition), along with mixed neuroendocrine-non-neuroendocrine neoplasms. NECs are always aggressive, with multiple mutations; they are treated with chemotherapy. NETs have widely different presentations, behavior, and management depending on site of origin. Esophageal examples are vanishingly rare. Most gastric and appendiceal tumors are indolent, as are many colonic and rectal tumors. The duodenum is home to some unusual variants of NET, and jejunal/ileal NETs frequently metastasize, which impacts their staging and clinical management.
Identifiants
pubmed: 32773190
pii: S1875-9181(20)30026-X
doi: 10.1016/j.path.2020.04.002
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
377-397Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.